Literature DB >> 31371421

Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).

Andaleeb Sajid1, Natarajan Raju1, Sabrina Lusvarghi1, Shahrooz Vahedi1, Rolf E Swenson1, Suresh V Ambudkar2.   

Abstract

Fluorescent conjugates of drugs can be used to study cellular functions and pharmacology. These compounds interact with proteins as substrates or inhibitors, helping in the development of unique fluorescence-based methods to study in vivo localization and molecular mechanisms. P-glycoprotein (P-gp, ABCB1) is an ATP-binding cassette (ABC) transporter that effluxes most anticancer drugs from cells, contributing to the development of drug resistance. To study the transport function of P-gp, we synthesized a Bodipy-labeled fluorescent conjugate of cyclosporine A (BD-CsA). After synthesis and characterization of its chemical purity, BD-CsA was compared with the commonly used 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD)-CsA probe. In flow cytometry assays, the fluorescence intensity of BD-CsA was almost 10 times greater than that of NBD-CsA, enabling us to use significantly lower concentrations of BD-CsA to achieve the same fluorescence levels. We found that BD-CsA is recognized as a transport substrate by both human and mouse P-gp. The rate of efflux of BD-CsA by human P-gp is comparable to that of NBD-CsA. The transport of BD-CsA was inhibited by tariquidar, with similar IC50 values to those for NBD-CsA. BD-CsA and NBD-CsA both partially inhibited the ATPase activity of P-gp with similar IC50 values. In silico docking of BD-CsA and NBD-CsA to the human P-gp structure indicates that they both bind in the drug-binding pocket with similar docking scores and possibly interact with similar residues. Thus, we demonstrate that BD-CsA is a sensitive fluorescent substrate of P-gp that can be used to efficiently study the transporter's localization and function in vitro and in vivo. SIGNIFICANCE STATEMENT: The goal of this study was to develop an effective probe to study drug transport by P-glycoprotein (P-gp). Fluorophore-conjugated substrates are useful to study the P-gp transport mechanism, structural characteristics, and development of its inhibitors. Cyclosporine A (CsA), a cyclic peptide comprising 11 amino acids, is a known substrate of P-gp. P-gp affects CsA pharmacokinetics and interactions with other coadministered drugs, especially during transplant surgeries and treatment of autoimmune disorders, when CsA is given as an immunosuppressive agent. We synthesized and characterized Bodipy-FL-CsA as an avid fluorescent substrate that can be used to study the function of P-gp both in vitro and in vivo. We demonstrate that Bodipy-FL-conjugation does not affect the properties of CsA as a P-gp substrate. U.S. Government work not protected by U.S. copyright.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31371421      PMCID: PMC6744393          DOI: 10.1124/dmd.119.087734

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  60 in total

1.  Python: a programming language for software integration and development.

Authors:  M F Sanner
Journal:  J Mol Graph Model       Date:  1999-02       Impact factor: 2.518

Review 2.  Molecular basis of the polyspecificity of P-glycoprotein (ABCB1): recent biochemical and structural studies.

Authors:  Eduardo E Chufan; Hong-May Sim; Suresh V Ambudkar
Journal:  Adv Cancer Res       Date:  2015-01-08       Impact factor: 6.242

3.  Differential Coupling of Binding, ATP Hydrolysis, and Transport of Fluorescent Probes with P-Glycoprotein in Lipid Nanodiscs.

Authors:  Mavis Jiarong Li; Abhinav Nath; William M Atkins
Journal:  Biochemistry       Date:  2017-05-04       Impact factor: 3.162

4.  Differential sensitivities of the human ATP-binding cassette transporters ABCG2 and P-glycoprotein to cyclosporin A.

Authors:  Karin F K Ejendal; Christine A Hrycyna
Journal:  Mol Pharmacol       Date:  2004-12-14       Impact factor: 4.436

5.  Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation.

Authors:  Youngjin Kim; Jue Chen
Journal:  Science       Date:  2018-01-25       Impact factor: 47.728

6.  Use of baculovirus BacMam vectors for expression of ABC drug transporters in mammalian cells.

Authors:  Suneet Shukla; Candice Schwartz; Khyati Kapoor; Abdul Kouanda; Suresh V Ambudkar
Journal:  Drug Metab Dispos       Date:  2011-10-31       Impact factor: 3.922

7.  Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins.

Authors:  Attaphol Pawarode; Suneet Shukla; Hans Minderman; Stacy M Fricke; Elaine M Pinder; Kieran L O'Loughlin; Suresh V Ambudkar; Maria R Baer
Journal:  Cancer Chemother Pharmacol       Date:  2006-10-10       Impact factor: 3.333

Review 8.  The power of the pump: mechanisms of action of P-glycoprotein (ABCB1).

Authors:  Suresh V Ambudkar; In-Wha Kim; Zuben E Sauna
Journal:  Eur J Pharm Sci       Date:  2005-12-13       Impact factor: 4.384

9.  Correlation between steady-state ATP hydrolysis and vanadate-induced ADP trapping in Human P-glycoprotein. Evidence for ADP release as the rate-limiting step in the catalytic cycle and its modulation by substrates.

Authors:  K M Kerr; Z E Sauna; S V Ambudkar
Journal:  J Biol Chem       Date:  2000-12-19       Impact factor: 5.157

10.  The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein.

Authors:  C Martin; G Berridge; P Mistry; C Higgins; P Charlton; R Callaghan
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

View more
  7 in total

Review 1.  Non-ionic Surfactants as a P-Glycoprotein(P-gp) Efflux Inhibitor for Optimal Drug Delivery-A Concise Outlook.

Authors:  Sachin Rathod; Heta Desai; Rahul Patil; Jayant Sarolia
Journal:  AAPS PharmSciTech       Date:  2022-01-18       Impact factor: 3.246

Review 2.  MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy.

Authors:  Milad Ashrafizadeh; Hui Li Ang; Ebrahim Rahmani Moghadam; Shima Mohammadi; Vahideh Zarrin; Kiavash Hushmandi; Saeed Samarghandian; Ali Zarrabi; Masoud Najafi; Reza Mohammadinejad; Alan Prem Kumar
Journal:  Biomolecules       Date:  2020-07-12

3.  Reversing the direction of drug transport mediated by the human multidrug transporter P-glycoprotein.

Authors:  Andaleeb Sajid; Sabrina Lusvarghi; Megumi Murakami; Eduardo E Chufan; Biebele Abel; Michael M Gottesman; Stewart R Durell; Suresh V Ambudkar
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-09       Impact factor: 11.205

Review 4.  Strategies and Mechanism in Reversing Intestinal Drug Efflux in Oral Drug Delivery.

Authors:  Rong Lu; Yun Zhou; Jinqian Ma; Yuchen Wang; Xiaoqing Miao
Journal:  Pharmaceutics       Date:  2022-05-26       Impact factor: 6.525

Review 5.  Mamma Mia, P-glycoprotein binds again.

Authors:  Richard Callaghan; Ingrid C Gelissen; Anthony M George; Anika M S Hartz
Journal:  FEBS Lett       Date:  2020-10-20       Impact factor: 4.124

6.  Solid-phase fluorescent BODIPY-peptide synthesis via in situ dipyrrin construction.

Authors:  Yue Wu; Wing-Sze Tam; Ho-Fai Chau; Simranjeet Kaur; Waygen Thor; Wei Shen Aik; Wai-Lun Chan; Markus Zweckstetter; Ka-Leung Wong
Journal:  Chem Sci       Date:  2020-09-24       Impact factor: 9.825

7.  Creation of Fluorescent RXR Antagonists Based on CBTF-EE and Application to a Fluorescence Polarization Binding Assay.

Authors:  Maho Takioku; Yuta Takamura; Michiko Fujihara; Masaki Watanabe; Shoya Yamada; Mayu Kawasaki; Sohei Ito; Shogo Nakano; Hiroki Kakuta
Journal:  ACS Med Chem Lett       Date:  2021-05-07       Impact factor: 4.632

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.